Informational Only · Not Medical Advice · Consult a Dermatologist · Editorial Policy
What Is New With Whiteheads and Acne in September 2026? Latest FDA and dermatology sources and Key Takeaways - Featured image

What Is New With Whiteheads and Acne in September 2026? Latest FDA and dermatology sources and Key Takeaways

by

The biggest change for whiteheads in 2026 is that the strongest over-the-counter option ever cleared for comedonal acne is now on shelves: the FDA approved Differin Epiduo Acne Gel — adapalene 0.1% with benzoyl peroxide 2.5% — for nonprescription use in people 12 and older on May 22, 2026. The second change affects anyone on or considering isotretinoin: modified iPLEDGE rules took effect August 8, 2026, allowing at-home pregnancy testing during treatment and dropping monthly counseling paperwork. Whiteheads (closed comedones) form when dead skin cells and oil plug a follicle and the opening seals over. That is a keratinization problem, not an infection, which is why the ingredients below matter more than any cleanser claim.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Official resources:

Table of Contents

The OTC switch that changes what you can buy for whiteheads

Adapalene is a topical retinoid that normalizes follicular keratinization — the plugging process that creates whiteheads and blackheads. Benzoyl peroxide works differently: it is an antimicrobial and a keratolytic, meaning it also helps break down the plug. According to Galderma's approval announcement, pairing them is why this product targets comedonal acne and not just red, inflamed pimples. This is the first Rx-to-OTC switch of a fixed-dose retinoid plus benzoyl peroxide combination.

Adapalene alone went OTC years ago; the combination did not. Galderma reports the gel reached Walmart, Target, Ulta and Amazon starting in summer 2026, per the FDA approval summary on Drugs.com. The practical consequence cuts both ways. You no longer need an appointment to get it — and no clinician screens you first for irritation risk or for the pregnancy questions that come with any retinoid.

How to start it without wrecking your skin barrier

Retinoid plus benzoyl peroxide is a strong pairing for a first-time user. The purging and dryness that make people quit usually come from starting daily at full face coverage. If you can become pregnant, ask a pharmacist or clinician about retinoid use before starting, since nobody will raise it for you at the checkout.

  • Start every other night, not nightly, for the first two to three weeks.
  • Use a pea-sized amount for the whole face — more product does not clear faster.
  • Apply to dry skin; damp skin increases absorption and irritation.
  • Moisturize after, not instead. A plain moisturizer does not cancel the active.
  • Expect six to twelve weeks before judging results. Comedones turn over slowly.

What the iPLEDGE changes mean if you take isotretinoin

Isotretinoin is the oral retinoid used for severe or scarring acne, and iPLEDGE is the FDA safety program that controls access to it because the drug causes serious birth defects. The FDA approved modifications to that program on February 9, 2026, with a 180-day runway; the FDA's iPLEDGE questions and answers page confirms the changes took effect on August 8, 2026. Three things changed. Prescribers may now permit at-home pregnancy testing during and after treatment, though pre-treatment testing must still happen in a medical setting. Monthly REMS counseling documentation is gone.

And the 30-day prescription pickup window has been dropped for patients who cannot become pregnant, as summarized in Dermatology Times' report on the modifications. The pickup-window change is the one patients feel most. Missing a narrow window used to mean restarting a month of the process. Note the limit: these are permissions for prescribers, not automatic entitlements. Your dermatologist decides whether at-home testing applies to you.

The benzene question hanging over benzoyl peroxide

Benzoyl peroxide can degrade into benzene, a known carcinogen, at high temperatures. That chemistry drove voluntary recalls of specific lots of La Roche-Posay Effaclar Duo, Proactiv Emergency Blemish Relief, SLMD Benzoyl Peroxide Acne Lotion and Walgreens acne products, as documented in the American Academy of Dermatology's benzoyl peroxide FAQ. Hold that alongside the FDA's own assessment. The agency states the cancer risk from the benzene levels found is "very low," and says there is no clear evidence that benzoyl peroxide acne products carry dangerous benzene levels.

Third-party laboratories have reported more contamination than FDA testing found — a gap that has not been resolved in consumers' favor or against them. The action item is small and free: store these products cool. Not in a steamy bathroom, not in a parked car in August. Heat is the variable you control.

What dermatology guidelines still recommend first

The AAD's current acne guideline, published in the Journal of the American Academy of Dermatology in 2024, makes strong recommendations for benzoyl peroxide, topical retinoids, topical antibiotics and oral doxycycline. It also strongly recommends fixed-dose combinations, which is the category the new OTC gel falls into. Two details are worth knowing before you pay more for a premium retinoid.

The guideline notes that no topical retinoid is proven superior to another — tretinoin, adapalene and tazarotene are not ranked against each other. And topical antibiotics should be paired with benzoyl peroxide to limit bacterial resistance, never used alone long-term. For teenagers whose whiteheads track with their cycle, the AAD advises against oral contraceptives for acne in patients under 16 until at least two years past menarche. That is a timing rule, not a permanent exclusion.

What is in the pipeline, and what is not available yet

Sagimet Biosciences plans to begin a US Phase 3 trial of oral denifanstat in moderate-to-severe acne in the second half of 2026, according to the company's SEC filing. Denifanstat is a FASN inhibitor — it blocks fatty acid synthase to reduce how much sebum the skin produces, a different mechanism from anything currently prescribed. If it succeeds, it would be the first novel oral acne drug in roughly 40 years.

Phase 3 is the last stage before a filing, and it typically runs years rather than months. Nothing is approved, and no prescriber can write for it today. Treat it as a reason to stay with a working regimen rather than a reason to wait for one. The adapalene–benzoyl peroxide combination on the shelf this month is the one that can start clearing a whitehead in your next six weeks.

Frequently Asked Questions

Is the OTC version the same strength as the prescription one?

The approved nonprescription gel is adapalene 0.1% with benzoyl peroxide 2.5%, cleared for ages 12 and older. Higher prescription concentrations of either ingredient still exist and still require a clinician.

Should I stop using benzoyl peroxide because of the benzene recalls?

The FDA says the cancer risk from the levels found is very low and that there is no clear evidence these products carry dangerous benzene levels. Check whether your specific lot was recalled, and store the product away from heat.

Can I use the new gel with a separate retinoid serum?

Layering two retinoids raises irritation without evidence of faster clearing, and the AAD guideline notes no topical retinoid is proven superior to another. Pick one and give it eight to twelve weeks.

You Might Also Like

Browse more: Acne | Acne Scars | Adults | Back | Blackheads

We use cookies to run this site, measure how it’s used, and show ads. Choose “Essentials only” to limit cookies to what the site needs to work. Privacy Policy.